Cell and Gene Therapy Market Size and Forecast (2021 – 2031)

Process Development Segment, by Services to Account the Largest Share in Cell and Gene Therapy Market during 2023–2031

According to our new research study on “Cell And Gene Therapy Market Forecast to 2031 – Global Analysis – by Type, Services, Scale, Service Provider, and End User,” the market is expected to grow from US$ 4.48 billion in 2023 to US$ 28.05 billion by 2031; it is anticipated to record a CAGR of 25.8% from 2023 to 2031. The cell and gene therapy market report emphasizes trends prevalent in the global market, along with drivers and deterrents affecting its growth.

Automation of Cell and Gene Therapy Manufacturing Services Acts as a Trend of Cell And Gene Therapy Market Growth

Incorporating automation in cell and gene therapy manufacturing can lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices designed to boost the automation of most sequential unit operations for a CAR-T process within a single system. With the rise in demand for cell and gene therapies, the production of cell and gene therapy products has shifted from a small-volume process to a large-volume process worldwide. In addition to the increasing research activities, the evolution of cell and gene therapy from an academic and clinical setting to commercialization has propelled the demand for automation in commercial manufacturing.

In May 2024, Ori Biotech launched IRO platform, an automated manufacturing platform. It’s a piece of manufacturing tech designed to be space- and cost-efficient. The company says its tech is flexible enough to transition between projects at various stages of development. Further, government agencies are adopting automation in the manufacturing of cell therapies to increase national production capabilities. For instance, as of March 2023, the UK Stem Cell Bank of the Medicines and Healthcare Products Regulatory Agency (MHRA) was testing automated robotic technology for developing stem cell technology for the manufacturing of stem cell-based therapies. Thus, automation of cell and gene therapy manufacturing services is expected to bring new trends in the cell and gene therapy market in the coming years.

The cell and gene therapy market, by type, the cell and gene therapy market is segmented into bifurcated into cell therapy, gene therapy. The cell therapy segment held a larger market share in 2023.

The cell and gene therapy market, by services, the market is segmented into process development, cGMP manufacturing, regulatory services, bioassay services. The process development segment held a larger share of the market in 2023.

The cell and gene therapy market, by scale, the market is bifurcated into pre commercial/R and D manufacturing, commercial scale manufacturing. The pre commercial/R and D manufacturing segment held a larger share of the market in 2023.

The cell and gene therapy market, by service provider, the market is divided into CDMOs, CMOs. The CDMOs segment held a larger share of the market in 2023.

The cell and gene therapy market, by end user, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, academic and research institutes. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.

Thermo Fisher Scientific, Inc., Merck KGaA, Charles River Laboratories, Cell and Gene Therapy Catapult, Lonza, WuXi AppTec, Takara Bio Inc., Bristol Myers Squibb, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd., and Catalent Biologics are among the leading companies operating in the global arterial blood gas kits market.

Companies operating in the cell and gene therapy market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the arterial blood gas kits market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall cell and gene therapy market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the cell and gene therapy market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the cell and gene therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the cell and gene therapy market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Cell and Gene Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Cell and Gene Therapy Market – Key Market Dynamics
5.1 Cell and Gene Therapy Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Number of Approval of Cell and Gene Therapies
5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:
6. Cell and Gene Therapy Market – Global Market Analysis
6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021–2031
6.2 Cell and Gene Therapy Market Forecast Analysis
7. Cell and Gene Therapy Market Analysis – by Type
7.1 Cell Therapy
7.1.1 Overview
7.1.2 Cell Therapy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8. Cell and Gene Therapy Market Analysis – by Services
8.1 Process Development
8.1.1 Overview
8.1.2 Process Development: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
8.2.1 Overview
8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
8.3.1 Overview
8.3.2 Regulatory Services: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
8.4.1 Overview
8.4.2 Bioassay Services: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9. Cell and Gene Therapy Market Analysis – by Scale
9.1 Pre Commercial/R and D Manufacturing
9.1.1 Overview
9.1.2 Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
9.2.1 Overview
9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
10. Cell and Gene Therapy Market Analysis – by Service Providers
10.1 CDMOs
10.1.1 Overview
10.1.2 CDMOs: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
10.2.1 Overview
10.2.2 CMOs: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
11. Cell and Gene Therapy Market Analysis – by End User
11.1 Contract Research Organizations
11.1.1 Overview
11.1.2 Contract Research Organizations: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12. Cell and Gene Therapy Market – Geographical Analysis
12.1 Overview
12.2 North America
12.2.1 North America Cell and Gene Therapy Market Overview
12.2.2 North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3 North America: Cell and Gene Therapy Market Breakdown, by Type
12.2.3.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.2.3.1.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.2.3.1.2 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.2.4 North America: Cell and Gene Therapy Market Breakdown, by Services
12.2.4.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.2.5 North America: Cell and Gene Therapy Market Breakdown, by Scale
12.2.5.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.2.6 North America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.6.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.2.7 North America: Cell and Gene Therapy Market Breakdown, by End User
12.2.7.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.2.8 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.2.8.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.2.8.2 United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.2.8.2.1 United States: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.2.1.1 United States: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.2.1.2 United States: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.2.2 United States: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.2.3 United States: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.2.4 United States: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.2.5 United States: Cell and Gene Therapy Market Breakdown, by End User
12.2.8.3 Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.2.8.3.1 Canada: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.3.1.1 Canada: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.3.1.2 Canada: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.3.2 Canada: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.3.3 Canada: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.3.4 Canada: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.3.5 Canada: Cell and Gene Therapy Market Breakdown, by End User
12.2.8.4 Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.2.8.4.1 Mexico: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.4.1.1 Mexico: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.4.1.2 Mexico: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.4.2 Mexico: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.4.3 Mexico: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.4.4 Mexico: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.4.5 Mexico: Cell and Gene Therapy Market Breakdown, by End User
12.3 Europe
12.3.1 Europe Cell and Gene Therapy Market Overview
12.3.2 Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3 Europe: Cell and Gene Therapy Market Breakdown, by Type
12.3.3.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.3.3.1.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.3.3.1.2 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.3.4 Europe: Cell and Gene Therapy Market Breakdown, by Services
12.3.4.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.3.5 Europe: Cell and Gene Therapy Market Breakdown, by Scale
12.3.5.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.3.6 Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.6.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.3.7 Europe: Cell and Gene Therapy Market Breakdown, by End User
12.3.7.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.3.8 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.3.8.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.3.8.2 United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.3 Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.4 France: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.5 Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.6 Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.7 Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User
12.4 Asia Pacific
12.4.1 Asia Pacific Cell and Gene Therapy Market Overview
12.4.2 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type
12.4.3.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.4.3.1.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.4.3.1.2 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.4.4 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services
12.4.4.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.4.5 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale
12.4.5.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.4.6 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.6.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.4.7 Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User
12.4.7.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.4.8 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.4.8.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.4.8.2 China: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.2.1 China: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.2.1.1 China: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.2.1.2 China: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.2.2 China: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.2.3 hina: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.2.4 China: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.2.5 China: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.3 Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.3.1 Japan: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.3.1.1 Japan: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.3.1.2 Japan: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.3.2 Japan: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.3.3 Japan: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.3.4 Japan: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.3.5 Japan: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.4 India: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.4.1 India: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.4.1.1 India: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.4.1.2 India: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.4.2 India: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.4.3 India: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.4.4 India: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.4.5 India: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.5 Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.5.1 Australia: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.5.1.1 Australia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.5.1.2 Australia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.5.2 Australia: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.5.3 Australia: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.5.4 Australia: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.5.5 Australia: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.6 South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.6.1 South Korea: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.6.1.1 South Korea: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.6.1.2 South Korea: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.6.2 South Korea: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.6.3 South Korea: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.6.4 South Korea: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.6.5 South Korea: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.7 Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.7.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.7.1.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.7.1.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.7.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.7.3 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.7.4 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.7.5 Rest of APAC: Cell and Gene Therapy Market Breakdown, by End User
12.5 Middle East and Africa
12.5.1 Middle East and Africa Cell and Gene Therapy Market Overview
12.5.2 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.3 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.3.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.5.3.1.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.5.3.1.2 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.5.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.4.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.5.5 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.5.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.5.6 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.6.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.5.7 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
12.5.7.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.5.8 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.5.8.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.5.8.2 South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.8.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.3 Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.8.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.4 United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.8.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.5 Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.8.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
12.6 South and Central America
12.6.1 South and Central America Cell and Gene Therapy Market Overview
12.6.2 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.6.3 South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.6.3.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.6.3.1.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.6.3.1.2 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.6.4 South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.6.4.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.6.5 South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.6.5.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.6.6 South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.6.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.6.7 South and Central America: Cell and Gene Therapy Market Breakdown, by End User
12.6.7.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.6.8 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.6.8.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.6.8.2 Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.6.8.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
12.6.8.3 Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.6.8.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
12.6.8.4 Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.6.8.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Cell and Gene Therapy Catapult
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Lonza Group AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 WuXi AppTec Co Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Takara Bio Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 FUJIFILM Holdings Corp
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 F. Hoffmann-La Roche Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Catalent Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Lotte Corp
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The the Reporting Teams
15.2 Glossary of Terms

LIST OF TABLES

Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Cell Therapy
Table 5. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Gene Therapy
Table 6. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Services
Table 7. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Scale
Table 8. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Service Providers
Table 9. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 11. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 12. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 13. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 14. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 15. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 16. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 17. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 18. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 19. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 20. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 21. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 22. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 23. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 24. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 25. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 26. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 27. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 28. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 29. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 30. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 31. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 32. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 33. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 34. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 35. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 36. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 37. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 38. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 39. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 40. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 41. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 42. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 43. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 44. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 45. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 46. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 47. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 48. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 49. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 50. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 51. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 52. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 53. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 54. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 55. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 56. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 57. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 58. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 59. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 60. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 61. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 62. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 63. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 64. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 65. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 66. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 67. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 68. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 69. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 70. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 71. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 72. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 73. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 74. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 75. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 76. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 77. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 78. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 79. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 80. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 81. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 82. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 83. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 84. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 85. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 86. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 87. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 88. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 89. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 90. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 91. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 92. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 93. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 94. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 95. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 96. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 97. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 98. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 99. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 100. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 101. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 102. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 103. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 104. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 105. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 106. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 107. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 108. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 109. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 110. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 111. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 112. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 113. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 114. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 115. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 116. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 117. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 118. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 119. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 120. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 121. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 122. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 123. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 124. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 125. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 126. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 127. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 128. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 129. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 130. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 131. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 132. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 133. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 134. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 135. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 136. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 137. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 138. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 139. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 140. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 141. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 142. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 143. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 144. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 145. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 146. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 147. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 148. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 149. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 150. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 151. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 152. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 153. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 154. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 155. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 156. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 157. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 158. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 159. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 160. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 161. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 162. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 163. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 164. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 165. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 166. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 167. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 168. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 169. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 170. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 171. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 172. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 173. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 174. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 175. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 176. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 177. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 178. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 179. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 180. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 181. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 182. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 183. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 184. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 185. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 186. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 187. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 188. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 189. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 190. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 191. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 192. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 193. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 194. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 195. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 196. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 197. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 198. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 199. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 200. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 201. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 202. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 203. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 204. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 205. Recent Inorganic Growth Strategies in the Tympanostomy products Market

LIST OF FIGURES

Figure 1. Cell and Gene Therapy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Cell and Gene Therapy Market Revenue (US$ Million), 2021–2031
Figure 5. Cell and Gene Therapy Market Share (%) – by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) – by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) – by Scale (2023 and 2031)
Figure 14. Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) – by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) – by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Cell and Gene Therapy Market Breakdown by Region, 2023 and 2031 (%)
Figure 24. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. North America: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 26. North America: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 27. North America: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 28. North America: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 29. North America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 35. Europe: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 36. Europe: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 37. Europe: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 38. Europe: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 39. Europe: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 40. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 48. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 49. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 50. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 51. Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 52. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 53. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 60. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 61. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 62. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 63. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 64. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 65. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 66. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 68. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 69. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. South and Central America: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 72. South and Central America: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 73. South and Central America: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 74. South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 75. South and Central America: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 76. South and Central America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 77. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 78. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 79. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 80. Growth Strategies in Cell and Gene Therapy Market